GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
Clinical trial NCT03029351 · TERMINATED
Trial details
- NCT number
- NCT03029351
- Sponsor
- University at Buffalo
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2019-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.